Drugs / EMLA Cream
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04026074 | Jul → Oct 2019 | arthropathy | Medical University of Graz | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EMLA Cream | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04026074 ↗ |
| Route | Other | “administered intravenously (fentanyl-bolus, remifentanil-infusion, clonidine-bolus) or transcutaneously (EMLA salve)” NCT04026074 ↗ |